It’s been an eventful week on the pipeline front with companies like Biogen Inc (NASDAQ:BIIB), Prothena Corporation PLC (NASDAQ:PRTA) and Vertex Pharmaceuticals Incorporated …
Gilead Sciences Inc (NASDAQ: GILD) issued a new warning about its hepatitis C drugs after discovering a dangerous interaction with amiodarone, a drug that …
William Blair's healthcare analyst John Sonnier came out today with a few insights on Gilead Sciences, Inc. (NASDAQ:GILD), after the company sent warnings to health providers about potentially fatal risks …
Just a day after Retrophin Inc. (NASDAQ:RTRX) announced a $100 million financing the U.
2014 was an eventful year on Wall Street with many ups and downs. Now that 2015 is here, many investors have been wondering …
Recently, I wrote about stocks that gave investors a big move in dividend payments. Investors are expecting a 50 percent higher dividend income.
In a research report sent to investors today, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Gilead Sciences (NASDAQ:GILD) with a …
Highlights: – The biggest concerns this quarter remain the stronger dollar, global weakness and lower oil prices. – The S&P 500 currently has …
Gilead Sciences (NASDAQ: GILD) dropped roughly 10% in morning trading on Wednesday, February 4th following the announcement of its fourth quarter 2014 earnings results the …
Great earnings results over the past couple of days has boosted S&P 500 blended growth up to 6.4% from 6.
